/

Beam Therapeutics

Develops precision genetic medicines using base editing technology.

BiotechnologyGenomics

Company facts

Founded: 2017
Employees: 575
Headquarters: United States
Type: Public
Listed: NASDAQ: BEAM
Subsidiaries: GuideTX